Mental Health IssueNCT06502717
Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Disorders
A study testing VIOME Precision Nutrition Program in people with Mental Health Issue and Depression, run by Viome at 1 site in United States.
Trial summary
US residents who have mental health issues sign the informed consent form and are screened and enrolled for this study. Participants complete a survey upon enrollment and are randomized into one of two study arms. This study is direct to participant and will NOT utilize clinical sites. Read more about this study
- Who is it for?
- Ages 25 to 75 years
- Conditions the study is for
- Mental Health Issue, Depression, Anxiety
- What is being tested?
- VIOME Precision Nutrition Program
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 150 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Jul 2024to Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Resident of the United States
- Females and males ages 25-75 (inclusive)
- Able to speak and read English
- No unexplained weight loss, fevers, anemia, or blood in stool
- Willing and able to follow the trial instructions, as described in the recruitment letter
- Signed and dated informed consent prior to any trial-specific procedures.
- PHQ9 score of 5-24 (inclusive)
Who cannot join
- Unwilling to change their current diet
- Prior use of Viome products or services
- Antibiotic use in the previous 4 weeks
- Pregnancy (current or planned in the next 4 months)
- < 90 days postpartum
- Breast feeding
Show all 24Show fewer
- Active infection
- Unable or unwilling to use Viome's App on an iPhone or Android smartphone
- Significant diet or lifestyle change in the previous 1 month
- IBD diagnosis -Major psychiatric/DSM-4 disease diagnosis (e.g. Schizophrenia, Bipolar disorder, Post- traumatic Stress Disorder, Obsessive Compulsive disorder)
- Use of investigational drugs, products or devices within 1 month prior to and 4 months after the start of the trial
- Cancer therapy within the previous 1 year
- Major surgery in the last 6 months or planned in the next 4 months
- Allergies to any supplement ingredients listed in the screening survey
- Currently on a specific diet: FODMAP, KETO, PALEO
- Answered yes to the question, "In the past few weeks, have you wished you were dead or had thoughts about killing yourself?"
- Gastrointestinal disease including:
- GI surgery except:
- Appendectomy and benign polypectomy
- Esophagitis
- Celiac disease
- GI malignancy or obstruction
- Peptic Ulcer Disease
- Duodenal or gastric ulcer disease
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
Viome Life Sciences
Bothell, Washington, 98011
Momchilo Vuyisich, PhD, (425) 300-6933, studies@viome.com
Mory Mehrtash, MSHS, (425) 300-6933, studies@viome.com
About this study
Official title: Testing the Efficacy of Viome-designed Condition-based Supplements and Viome Precision Supplements to Improve Clinical Outcomes for Mental Health Conditions
US residents who have mental health issues sign the informed consent form and are screened and enrolled for this study. Participants complete a survey upon enrollment and are randomized into one of two study arms. This study is direct to participant and will NOT utilize clinical sites.
Read the detailed description
Participants who meet the eligibility criteria are randomized into any of the two study arms including: the placebo arm or the VIOME Precision Nutrition Program (VPNP) arm.
Placebo and Viome's Precision Nutrition Program include supplements, may include dietary recommendations towards improving the symptoms associated with mental health. The trial will last approximately 4 months for each participant.
- Conditions
- Mental Health Issue, Depression, Anxiety
- Being tested
- VIOME Precision Nutrition Program
- Keywords
- mental health, diet, supplements, vitamins, stress
- Medical subject headings
- Depression, Anxiety Disorders, Psychological Well-Being
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
VIOME Precision Nutrition ProgramCombination product
Also called VPNP
Precision supplement based on the participants microbiome sample results. Participants in this arm may have any combination of supplements, diet recommendations, and/or coaching.
| Study group | Role | What they receive |
|---|---|---|
| Placebo | No intervention | Participants who have mental health issues are randomized into this study arm. They may be provided with any combination of nutritional recommendations and supplements. Placebo capsules will contain inert or inactive ingredients. Participants may need to use a mobile app in order to participate in the trial. |
| Viome's Precision Nutrition Program (VPNP) | Active comparator | Participants who have mental health issues are randomized into this arm. They may be provided with any combination of nutritional recommendations and supplements. Participants may need to use a mobile app in order to participate in the trial. Receives: Combination Product: VIOME Precision Nutrition Program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduced PHQ-9 Score
Reduced PHQ-9 score for the VPNP group compared to baseline scores.
Measured: ~4 months
Reduced GAD-7 Score
Reduced GAD-7 score for the VPNP groups compared to baseline scores.
Measured: ~4 months
Reduced Perceived Stress Scale Score
Reduced Perceived Stress Scale score for the VPNP group compared to baseline scores.
Measured: ~4 months
Increased Quality of Life Score
Increased quality of life score for the VPNP group compared to baseline scores.
Measured: ~4 months
Correlation between microbial changes and clinical outcomes
Correlation between microbial changes on the VPNP with clinical outcomes.
Measured: ~4 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jul 2024
- Study start8 Jul 2024
- Primary completionDec 2025 (estimated)
- Study completionDec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental Health IssueStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized, blinded, cohort study divided into two study arms: 1) control group (placebo), 2) precision-supplement
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Viome
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Momchilo Vuyisich, Principal investigator, Viome
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06502717
- Sponsor's protocol ID
- V211.3_v2
- Status last verified
- Jun 2024
- First submitted
- 25 Jun 2024
- Last updated
- 29 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Testing the Efficacy of Viome-designed Condition-based Supplements and Viome Precision Supplements to Improve Clinical Outcomes for Mental Health Conditions
- ClinicalTrials.gov ID
- NCT06502717
- Acronym / sponsor ID
- V211.3_v2
- Conditions
- Mental Health Issue, Depression, Anxiety
- Keywords
- mental health, diet, supplements, vitamins, stress
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- ViomeIndustry (pharma, biotech, devices)
- Study start
- 8 Jul 2024 (actual)
- Primary completion
- Dec 2025 (estimated)
- Study completion
- Dec 2025 (estimated)
- First posted
- 16 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
US residents who have mental health issues sign the informed consent form and are screened and enrolled for this study. Participants complete a survey upon enrollment and are randomized into one of two study arms. This study is direct to participant and will NOT utilize clinical sites.
Detailed description
Participants who meet the eligibility criteria are randomized into any of the two study arms including: the placebo arm or the VIOME Precision Nutrition Program (VPNP) arm.
Placebo and Viome's Precision Nutrition Program include supplements, may include dietary recommendations towards improving the symptoms associated with mental health. The trial will last approximately 4 months for each participant.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- Randomized, blinded, cohort study divided into two study arms: 1) control group (placebo), 2) precision-supplement
| Arm | Type | Receives |
|---|---|---|
| Placebo | No intervention | –Participants who have mental health issues are randomized into this study arm. They may be provided with any combination of nutritional recommendations and supplements. Placebo capsules will contain inert or inactive ingredients. Participants may need to use a mobile app in order to participate in the trial. |
| Viome's Precision Nutrition Program (VPNP) | Active comparator | Combination Product: VIOME Precision Nutrition ProgramParticipants who have mental health issues are randomized into this arm. They may be provided with any combination of nutritional recommendations and supplements. Participants may need to use a mobile app in order to participate in the trial. |
Who may qualify
- Ages
- 25 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Resident of the United States
- Females and males ages 25-75 (inclusive)
- Able to speak and read English
- No unexplained weight loss, fevers, anemia, or blood in stool
- Willing and able to follow the trial instructions, as described in the recruitment letter
Key exclusion criteria (24 listed)
- Unwilling to change their current diet
- Prior use of Viome products or services
- Antibiotic use in the previous 4 weeks
- Pregnancy (current or planned in the next 4 months)
- < 90 days postpartum
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| VIOME Precision Nutrition ProgramAlso: VPNPPrecision supplement based on the participants microbiome sample results. Participants in this arm may have any combination of supplements, diet recommendations, and/or coaching. | Combination product | Viome's Precision Nutrition Program (VPNP) |
Primary outcome
Reduced PHQ-9 Score
Time frame: ~4 months
Reduced PHQ-9 score for the VPNP group compared to baseline scores.
Reduced GAD-7 Score
Time frame: ~4 months
Reduced GAD-7 score for the VPNP groups compared to baseline scores.
Reduced Perceived Stress Scale Score
Time frame: ~4 months
Reduced Perceived Stress Scale score for the VPNP group compared to baseline scores.
Increased Quality of Life Score
Time frame: ~4 months
Increased quality of life score for the VPNP group compared to baseline scores.
Correlation between microbial changes and clinical outcomes
Time frame: ~4 months
Correlation between microbial changes on the VPNP with clinical outcomes.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2025.
Related trials for Mental Health Issue
Active, not recruiting
Improving Maternal Mental Health & SUD Screening and Treatment
Mental Health Issue, Substance Use Disorders
Recruiting
Family Spirit Strengths
Depressive Symptoms, Anxiety Disorders and Symptoms
RecruitingObservational study
Proximal Risk for Suicide in Adolescents
Suicide, Mental Health Issue
Recruiting
Striving Towards EmPowerment and Medication Adherence R01
Hiv, Mental Health Issue
Active, not recruiting
Determining the Effectiveness of Working Out Dads to Reduce Mental Health Difficulties in Fathers of Young Children
Mental Health Issue
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Momchilo Vuyisich principal investigator
Viome
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing VIOME Precision Nutrition Program in people with Mental Health Issue and Depression, run by Viome at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 24 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Mory Mehrtash ((425) 300-6933, studies@viome.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduced PHQ-9 Score (time frame: ~4 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2025; AzTrials last refreshed its copy on 1 Nov 2026.